Motilal Oswal sees 20% upside for Mahindra Finance on credible transformation attempt
With an eye on the approaching Indian Lok Sabha elections in 2024, Motilal Oswal anticipates a favorable growth trajectory for Mahindra Finance, consistent with the historical trend of stronger assets under management (AUM) growth during pre-election fiscal years
MOTILAL OSWAL FINANCIAL SERVICES LTD. - 532892 - Outcome Of Analyst/Institutional Investor(S) Meeting
Outcome of Analyst/Institutional Investor(s) Meeting MOTILAL OSWAL FINANCIAL SERVICES LTD. - 532892 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Pursuant to provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform the Exchange that the Finance Committee of the Compay at its Meeting held on August 21, 2023 has approved an allotment of 2,59,143 equity shares to those options grantees who had excercised their options under the Employee Stock Option Schemes of the Company.
Neutral Divi's Laboratories; target of Rs 3430: Motilal Oswal
Motilal Oswal recommended Neutral rating on Divi's Laboratories with a target price of Rs 3430 in its research report dated August 15, 2023.
Buy J K Cement; target of Rs 3600: Motilal Oswal
Motilal Oswal is bullish on J K Cement recommended buy rating on the stock with a target price of Rs 3600 in its research report dated August 16, 2023. MOTILAL OSWAL FINANCIAL SERVICES LTD. - 532892 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/Investor Meeting to be held on Wednesday, August 23, 2023 in Motilal Oswal Financial Services Limited Annual Global Investor Conference ('MOFSL AGIC') at Mumbai
Motilal Oswal Alternates announces its sixth real estate fund, to raise Rs 2,000 crore
The company said it will strategically focus on early-stage investments in mid-income/affordable residential projects across India's top eight cities, Mumbai, Delhi-NCR, Pune, Bengaluru etc.
Breakout Stocks: Motilal Oswal, Aurobindo Pharma and ESAB India rise 15-25% in a month. How should you trade on Wednesday?
Stocks that were in focus include names like Motilal Oswal which closed with gains of over 3%, Aurobindo Pharma which rose over 1% to a fresh 52-week high and ESAB India which settled 3% higher on Monday.
Buy Trent; target of Rs 2070: Motilal Oswal
Motilal Oswal is bullish on Trent recommended buy rating on the stock with a target price of Rs 2070 in its research report dated August 10, 2023.
Motilal Oswal's Siddhartha Khemka shares top short-term stock picks for retail investors
Siddhartha Khemka shared his perspective on the factors driving the bull run, potential threats to the current market rally, sectors with an optimistic outlook, and also shared short-term investment recommendations